MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$91,800K
(-622.83%↓ Y/Y)
Loss before income
taxes
-$79,500K
(-803.41%↓ Y/Y)
Provision for income taxes
$12,300K
(215.38%↑ Y/Y)
Other (income)
expense, net
$3,400K
(342.86%↑ Y/Y)
Labs
$353,100K
Immunohematology
$138,300K
Point Of Care
$112,800K
Molecular Diagnostics
$7,800K
Donor Screening
$7,800K
Interest expense, net
$51,100K
(27.75%↑ Y/Y)
Operating (loss) income
-$31,800K
(-197.55%↓ Y/Y)
Total revenues
$619,800K
(-10.54%↓ Y/Y)
Cost of sales,
excluding amortization of...
$356,000K
(1.86%↑ Y/Y)
Selling, marketing and
administrative
$199,300K
(6.58%↑ Y/Y)
Amortization of intangible
assets
$46,800K
(-2.50%↓ Y/Y)
Research and development
$44,900K
(-15.60%↓ Y/Y)
Restructuring, integration and
other charges
$4,400K
Other operating
expenses
$200K
(-96.88%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)